Yang JC - Search Results

1

Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer.

Yang JC, Sherry RM, Steinberg SM, Topalian SL, Schwartzentruber DJ, Hwu P, Seipp CA, Rogers-Freezer L, Morton KE, White DE, Liewehr DJ, Merino MJ, Rosenberg SA. Yang JC, et al. J Clin Oncol. 2003 Aug 15;21(16):3127-32. doi: 10.1200/JCO.2003.02.122. J Clin Oncol. 2003. PMID: 12915604 Free PMC article. Clinical Trial.

2

Intravenous administration of recombinant human macrophage colony-stimulating factor to patients with metastatic cancer: a phase I study.

Sanda MG, Yang JC, Topalian SL, Groves ES, Childs A, Belfort R Jr, de Smet MD, Schwartzentruber DJ, White DE, Lotze MT, et al. Sanda MG, et al. Among authors: yang jc. J Clin Oncol. 1992 Oct;10(10):1643-9. doi: 10.1200/JCO.1992.10.10.1643. J Clin Oncol. 1992. PMID: 1403042 Clinical Trial.

3

Clinical application of IL6 in cancer therapy.

Mulé JJ, Marcus SG, Yang JC, Weber JS, Rosenberg SA. Mulé JJ, et al. Among authors: yang jc. Res Immunol. 1992 Sep;143(7):777-9. doi: 10.1016/0923-2494(92)80023-e. Res Immunol. 1992. PMID: 1439156 Clinical Trial. No abstract available.

4

A pilot study of the combination of interleukin-2-based immunotherapy and radiation therapy.

Lange JR, Raubitschek AA, Pockaj BA, Spencer WF, Lotze MT, Topalian SL, Yang JC, Rosenberg SA. Lange JR, et al. Among authors: yang jc. J Immunother (1991). 1992 Nov;12(4):265-71. doi: 10.1097/00002371-199211000-00007. J Immunother (1991). 1992. PMID: 1477077 Clinical Trial.

5

A prospective study of the value of core needle biopsy and fine needle aspiration in the diagnosis of soft tissue masses.

Barth RJ Jr, Merino MJ, Solomon D, Yang JC, Baker AR. Barth RJ Jr, et al. Among authors: yang jc. Surgery. 1992 Sep;112(3):536-43. Surgery. 1992. PMID: 1519170

6

Surgical resection of metastatic renal cell carcinoma and melanoma after response to interleukin-2-based immunotherapy.

Sherry RM, Pass HI, Rosenberg SA, Yang JC. Sherry RM, et al. Among authors: yang jc. Cancer. 1992 Apr 1;69(7):1850-5. doi: 10.1002/1097-0142(19920401)69:7<1850::aid-cncr2820690729>3.0.co;2-i. Cancer. 1992. PMID: 1551067 Clinical Trial.

7

The use of interleukin-2 and lymphokine-activated killer cells for the treatment of patients with non-Hodgkin's lymphoma.

Weber JS, Yang JC, Topalian SL, Schwartzentruber DJ, White DE, Rosenberg SA. Weber JS, et al. Among authors: yang jc. J Clin Oncol. 1992 Jan;10(1):33-40. doi: 10.1200/JCO.1992.10.1.33. J Clin Oncol. 1992. PMID: 1727923

8

Immunotherapy with interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer with in situ primary cancers: a pilot study.

Spencer WF, Linehan WM, Walther MM, Haas GP, Lotze MT, Topalian SL, Yang JC, Merino MJ, Lange JR, Pockaj BA, et al. Spencer WF, et al. Among authors: yang jc. J Urol. 1992 Jan;147(1):24-30. doi: 10.1016/s0022-5347(17)37124-0. J Urol. 1992. PMID: 1729540

9

Relapse after response to interleukin-2-based immunotherapy: patterns of progression and response to retreatment.

Sherry RM, Rosenberg SA, Yang JC. Sherry RM, et al. Among authors: yang jc. J Immunother (1991). 1991 Oct;10(5):371-5. doi: 10.1097/00002371-199110000-00009. J Immunother (1991). 1991. PMID: 1790145

10

Murine studies using polyethylene glycol-modified recombinant human interleukin 2 (PEG-IL-2): antitumor effects of PEG-IL2 alone and in combination with adoptive cellular transfer.

Yang JC, Schwarz SL, Perry-Lalley DM, Rosenberg SA. Yang JC, et al. Lymphokine Cytokine Res. 1991 Dec;10(6):475-80. Lymphokine Cytokine Res. 1991. PMID: 1804310

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,776 results

Search Page

Filters